1-54652948-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039464.4(MROH7):āc.22A>Gā(p.Asn8Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,452,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001039464.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MROH7 | NM_001039464.4 | c.22A>G | p.Asn8Asp | missense_variant | 3/24 | ENST00000421030.7 | NP_001034553.3 | |
MROH7-TTC4 | NR_037639.2 | n.465A>G | non_coding_transcript_exon_variant | 3/33 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MROH7 | ENST00000421030.7 | c.22A>G | p.Asn8Asp | missense_variant | 3/24 | 2 | NM_001039464.4 | ENSP00000396622 | P2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000414 AC: 1AN: 241322Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 130770
GnomAD4 exome AF: 6.88e-7 AC: 1AN: 1452992Hom.: 0 Cov.: 47 AF XY: 0.00 AC XY: 0AN XY: 722286
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.22A>G (p.N8D) alteration is located in exon 3 (coding exon 1) of the MROH7 gene. This alteration results from a A to G substitution at nucleotide position 22, causing the asparagine (N) at amino acid position 8 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at